Conversely, up-regulation of EcSOD has been reported to inhibit both in vitro and in vivo growth as well as the oncogenic phenotype of breast cancer, prostate cancer, pancreas cancer, melanomas, and lung cancer [4, 29, 31–35], suggesting tumor suppressive effects of this antioxidant. This evidence concerns the gene SOD3 and breast carcinoma.